Not Many Are Piling Into Jaguar Health, Inc. (NASDAQ:JAGX) Stock Yet As It Plummets 39%

Simply Wall StFeb 28 05:05 ET

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value

Jaguar HealthFeb 27 00:00 ET

Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome With Intestinal Failure (SBS-IF)

Jaguar HealthFeb 19 00:00 ET

Jaguar Health Extends Collaboration With Streeterville to Develop P-300

TipRanksFeb 18 09:20 ET

Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300

Jaguar HealthFeb 18 00:00 ET

Jaguar's Mytesi Could Be Used to Treat GI Side Effects of GLP-1 Weight Loss Drugs

Seeking AlphaJan 29 09:55 ET